Authors
Loading...
Registry-based analysis reveals improved overall and relapse-free survival rates in myelodysplastic syndrome patients undergoing HSCT with cord blood.
Potter et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: